Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052091 · ClinicalTrials.gov registry record · Phase 3
Therapy for Depressed Elders With Thought Problems
A Phase 3 study of Depression and Cognition Disorders, sponsored by University of Washington.
- Completed
- Registry status
- Phase 3
- Development phase
- 221
- Enrollment target
- 2
- Study locations
NCT00052091 is a Phase 3 study of Depression and Cognition Disorders that has completed, run by University of Washington. The registered enrollment target is 221 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00052091, a Phase 3 study of Depression and Cognition Disorders, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 221 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effectiveness of Problem Solving Therapy and Brief Supportive Therapy in treating elderly patients with major depression and thought problems.
Conditions Studied
Interventions
- BEHAVIORAL Problem Solving Therapy
- BEHAVIORAL Brief Supportive Therapy
Study Locations (2)
California
- University of California at San Francisco - San Francisco
New York
- Weill Medical College of Cornell University - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052091
The ClinicalTrials.gov registry entry for NCT00052091 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (72% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Problem Solving Therapy is the first listed.
NCT00052091 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT00052091 about?
NCT00052091 is a clinical study titled "Therapy for Depressed Elders With Thought Problems". This study will compare the effectiveness of Problem Solving Therapy and Brief Supportive Therapy in treating elderly patients with major depression and thought problems.
What is the current status of trial NCT00052091?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 221 participants. The study started on 2002-09. Estimated completion is 2008-03.
What conditions does trial NCT00052091 study?
This clinical trial studies the following conditions: Depression, Cognition Disorders.
What interventions are being tested in trial NCT00052091?
The interventions under investigation include: Problem Solving Therapy (BEHAVIORAL), Brief Supportive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00052091?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00052091 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care
RECRUITING · Phase 3
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
RECRUITING · Phase 3
-
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
RECRUITING · Phase 3
-
Creatine for Depressed Male and Female Methamphetamine Users
RECRUITING · Phase 3
-
E-Mindfulness Approaches for Living After Breast Cancer
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.